pain. Pain localized to other parts of lower abdomen
Conditions
Interventions
Intervention 1: In the group A used of drugs (midazolam + fentanyl) 2 mg/kg bolus intravenous fentanyl and midazolam 0.03 mg/kg as a bolus. Intervention 2: In the group B is used the drug (hydroxyzine
Treatment - Drugs
In the group A used of drugs (midazolam + fentanyl) 2 mg/kg bolus intravenous fentanyl and midazolam 0.03 mg/kg as a bolus.
In the group B is used the drug (hydroxyzine + fentanyl) so that consumed two hours before colonoscopy, two tablets of 25 mg hydroxyzine and fentanyl 2 mg / kg intravenous bolus.
In the group C is injected intravenously drugs (ketorolac) so that 30 minutes before the colonoscopy 0.5mg / kg.
In the group D is injected intravenously drugs (ketorolac+ fentanyl) so that bolus intravenous fentanyl of 2 mg/kg, 30 minutes before the colonoscopy ketorolac 0.5 mg/kg.
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria :Non urgency of colonoscopy?At least 18 years of age for participant?Patient satisfaction?The lack of acute gastrointestinal bleeding?The patient is placed first under colonoscopy. Exclusion criteria:If the patient needs more medication at colonoscopy time?Sensitivity to patients' medication.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain patients-Patient satisfaction. Timepoint: 6 months. Method of measurement: standard questionnaires VAS and GHAA- 9.;Patients' satisfaction. Timepoint: 6 months. Method of measurement: standard questionnaires VAS and GHAA- 9. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Dabiri
Semnan University of Medical Sciences
Outcome results
None listed